Dual Therapy CagriSema Promising for Weight and Glycaemic Control US$ 28.54 Min. order: 1 piece ★★★★★ 4.0 (210 reviews) Sold : Login>>
GLP-1 Receptor Agonists for Weight Control: Emerging Insights from Clinical Trials and Future Perspectives US$ 22.60 Min. order: 1 piece ★★★★★ 4.7 (48 reviews) Sold : Login>>
CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 21.78 Min. order: 1 piece ★★★★★ 4.3 (146 reviews) Sold : Login>>